Published in Expert Rev Pharmacoecon Outcomes Res on June 01, 2004
The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol (2008) 3.14
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol (2009) 2.64
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol (2005) 2.26
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol (2004) 1.89
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer (2010) 1.84
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol (2007) 1.72
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer (2007) 1.62
Do quality-of-life randomized clinical trials support clinicians in their decision-making? J Clin Oncol (2002) 1.45
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med (2002) 1.28
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer (2005) 1.20
Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol (2004) 1.17
Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys (2012) 1.15
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer (2011) 1.14
Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer (2003) 1.14
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol (2008) 1.12
Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol (2003) 1.11
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes (2010) 1.11
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol (2004) 1.09
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer (2007) 1.07
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer (2008) 1.07
Fatigue and quality of life: lessons from the real world. Oncologist (2003) 1.02
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology (2012) 1.01
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol (2011) 1.00
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol (2008) 0.98
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol (2007) 0.97
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. Psychooncology (2013) 0.97
Treatment satisfaction as an outcome measure in cancer clinical treatment trials. Expert Rev Pharmacoecon Outcomes Res (2002) 0.94
Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer (2013) 0.94
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol (2013) 0.93
Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs. Int J Radiat Oncol Biol Phys (2003) 0.91
Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol (2008) 0.91
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data. Qual Life Res (2009) 0.90
When a parent has cancer: challenges to patients, their families and health providers. Expert Rev Pharmacoecon Outcomes Res (2012) 0.88
Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res (2009) 0.88
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer. J Clin Oncol (2005) 0.87
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. Eur J Cancer (2009) 0.86
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer (2013) 0.85
Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases. Qual Life Res (2013) 0.85
Standards are needed for quality of life clinical trials. BMJ (2002) 0.83
The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22. Expert Rev Pharmacoecon Outcomes Res (2013) 0.82
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Support Care Cancer (2012) 0.82
Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer. Expert Rev Pharmacoecon Outcomes Res (2013) 0.82
Comparison of three shortened questionnaires for assessment of quality of life in advanced cancer. J Palliat Med (2014) 0.82
Health-related quality of life in patients with brain tumors: limitations and additional outcome measures. Curr Neurol Neurosci Rep (2013) 0.81
Health-related quality of life and symptom research in glioblastoma multiforme patients. Expert Rev Pharmacoecon Outcomes Res (2005) 0.81
Trends in translation requests and arising issues regarding cultural adaptation. Expert Rev Pharmacoecon Outcomes Res (2011) 0.81
Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res (2014) 0.80
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res (2012) 0.80
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17. Support Care Cancer (2014) 0.79
The practical impact of differential item functioning analyses in a health-related quality of life instrument. Qual Life Res (2009) 0.79
Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review. Support Care Cancer (2014) 0.78
Joint modeling of longitudinal health-related quality of life data and survival. Qual Life Res (2014) 0.78
EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res (2015) 0.78
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative. Eur J Cancer Care (Engl) (2009) 0.77
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat Med (2006) 0.77
Factors influencing health related quality of life in cancer patients with bone metastases. J Palliat Med (2013) 0.77
An integrated psychological strategy for advanced colorectal cancer patients. Health Qual Life Outcomes (2006) 0.77
Interpretation of differential item functioning analyses using external review. Expert Rev Pharmacoecon Outcomes Res (2010) 0.77
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res (2011) 0.76
Quality of life in breast cancer patients: measurement issues in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res (2002) 0.76
The process of reconciliation: evaluation of guidelines for translating quality-of-life questionnaires. Expert Rev Pharmacoecon Outcomes Res (2012) 0.76
Confusion about European Organisation for Research and Treatment of Cancer Quality of Life Prostate module (EORTC QLQ-PR25): a response. Expert Rev Pharmacoecon Outcomes Res (2002) 0.75
Variability and sample size requirements for health-related quality-of-life measures: understanding the challenges facing investigators. J Clin Oncol (2005) 0.75
Palliative-care trials: how best to publish findings? Lancet Oncol (2008) 0.75
Guidelines for the use of epoetin: have quality-of-life benefits been proven? J Clin Oncol (2003) 0.75
External beam radiotherapy in prostate cancer patients: short- and long-term health-related quality of life issues. Expert Rev Pharmacoecon Outcomes Res (2003) 0.75
An evaluation of the response category translations of the EORTC QLQ-C30 questionnaire. Qual Life Res (2012) 0.75
Promoting pan-European cancer research for the benefit of all cancer patients. Expert Rev Pharmacoecon Outcomes Res (2012) 0.75
Health-related quality of life and cancer. Expert Rev Pharmacoecon Outcomes Res (2009) 0.75
Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Res (2015) 0.75
Fatigue assessment in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res (2002) 0.75